Cargando…

Tumor neoantigens: from basic research to clinical applications

Tumor neoantigen is the truly foreign protein and entirely absent from normal human organs/tissues. It could be specifically recognized by neoantigen-specific T cell receptors (TCRs) in the context of major histocompatibility complexes (MHCs) molecules. Emerging evidence has suggested that neoantige...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Tao, Shi, Tao, Zhang, Henghui, Hu, Jie, Song, Yuanlin, Wei, Jia, Ren, Shengxiang, Zhou, Caicun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731555/ https://www.ncbi.nlm.nih.gov/pubmed/31492199 http://dx.doi.org/10.1186/s13045-019-0787-5

Ejemplares similares

Heterogeneity of neoantigen landscape between primary lesions and their matched metastases in lung cancer
por: Jiang, Tao, et al.
Publicado: (2020)

Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications
por: Yu, Jie, et al.
Publicado: (2021)

Editorial: The Clinical Application of Neoantigens
por: Zhou, Jian-Guo, et al.
Publicado: (2022)

Multi-cancer blood testing combined with PET-CT: road for hope to screen for cancer and guide intervention
por: Jiang, Tao, et al.
Publicado: (2020)

The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
por: Li, Jiangping, et al.
Publicado: (2023)

Neoantigens and their potential applications in tumor immunotherapy
por: Fang, Xianzhu, et al.
Publicado: (2022)

Differences in treatment effect size between progression-free survival and overall survival in anti-PD-1/PD-L1 inhibitors-based trials in advanced NSCLC: a systematic review and meta-analysis
por: Zhou, Zhirui, et al.
Publicado: (2021)

Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma
por: Jiang, Tao, et al.
Publicado: (2021)

The Clinical Application of Neoantigens in Esophageal Cancer
por: Gu, Yi-Min, et al.
Publicado: (2021)

Pan-cancer analysis of ARID1A Alterations as Biomarkers for Immunotherapy Outcomes
por: Jiang, Tao, et al.
Publicado: (2020)

Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer()
por: Jiang, Tao, et al.
Publicado: (2017)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
por: Zhang, Zheying, et al.
Publicado: (2021)

Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
por: Jiang, Tao, et al.
Publicado: (2019)

Human organoids in basic research and clinical applications
por: Tang, Xiao-Yan, et al.
Publicado: (2022)

Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis
por: Jiang, Tao, et al.
Publicado: (2015)

Tumor neoantigens: Novel strategies for application of cancer immunotherapy
por: GUAN, HANYANG, et al.
Publicado: (2023)

Neoantigens in precision cancer immunotherapy: from identification to clinical applications
por: Zhang, Qiao, et al.
Publicado: (2022)

Neoantigens and their clinical applications in human gastrointestinal cancers
por: Eshkiki, Zahra Shokati, et al.
Publicado: (2022)

Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches
por: Huang, Ruichen, et al.
Publicado: (2023)

Front-line treatment for advanced non-small-cell lung cancer and ALK fusion: a network meta-analysis
por: Wen, Yaokai, et al.
Publicado: (2022)

Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
por: Pan, Ren-You, et al.
Publicado: (2018)

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
por: Jiang, Tao, et al.
Publicado: (2020)

Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer
por: Zhou, Fei, et al.
Publicado: (2020)

A Potent Micron Neoantigen Tumor Vaccine GP‐Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models
por: Jing, Zhe, et al.
Publicado: (2022)

The impact of EGFR exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancer
por: Zhao, Chao, et al.
Publicado: (2020)

Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker
por: He, Bingxi, et al.
Publicado: (2020)

Tumor-associated macrophages: from basic research to clinical application
por: Yang, Li, et al.
Publicado: (2017)

Neoantigen vaccine: an emerging tumor immunotherapy
por: Peng, Miao, et al.
Publicado: (2019)

Evolutionary dynamics of neoantigens in growing tumors
por: Lakatos, Eszter, et al.
Publicado: (2020)

Fibronectin promotes tumor angiogenesis and progression of non-small-cell lung cancer by elevating WISP3 expression via FAK/MAPK/ HIF-1α axis and activating wnt signaling pathway
por: Zhou, Fei, et al.
Publicado: (2023)

Personalized Neoantigen-Pulsed DC Vaccines: Advances in Clinical Applications
por: Tang, Lin, et al.
Publicado: (2021)

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
por: Nguyen, Kim Bich, et al.
Publicado: (2023)

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer
por: Zhou, Juan, et al.
Publicado: (2021)

NeoFox: annotating neoantigen candidates with neoantigen features
por: Lang, Franziska, et al.
Publicado: (2021)

Addition of bevacizumab for malignant pleural effusion as the manifestation of acquired EGFR-TKI resistance in NSCLC patients
por: Jiang, Tao, et al.
Publicado: (2017)

First-line continual EGFR-TKI plus local ablative therapy demonstrated survival benefit in EGFR-mutant NSCLC patients with oligoprogressive disease
por: Xu, Qinghua, et al.
Publicado: (2019)

LncRNAs: From Basic Research to Medical Application
por: Wu, Tao, et al.
Publicado: (2017)

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
por: Zhang, Rui, et al.
Publicado: (2019)

Applications of Functional Protein Microarrays in Basic and Clinical Research
por: Zhu, Heng, et al.
Publicado: (2012)

Personalised neoantigen‐based therapy in colorectal cancer
por: Zhu, Ya‐Juan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0e1lsh5cg5235dccm6jrlhuq3j